203 related articles for article (PubMed ID: 33023185)
1. High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm.
Roetzer A; Stich N; Model N; Schwameis M; Firbas C; Jilma B; Eibl MM
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33023185
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.
Narita K; Hu DL; Asano K; Nakane A
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568
[TBL] [Abstract][Full Text] [Related]
3. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
4. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
Spaulding AR; Lin YC; Merriman JA; Brosnahan AJ; Peterson ML; Schlievert PM
Vaccine; 2012 Jul; 30(34):5099-109. PubMed ID: 22691432
[TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial.
Schwameis M; Roppenser B; Firbas C; Gruener CS; Model N; Stich N; Roetzer A; Buchtele N; Jilma B; Eibl MM
Lancet Infect Dis; 2016 Sep; 16(9):1036-1044. PubMed ID: 27296693
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
Feng MH; Cui JC; Nakane A; Hu DL
Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection.
Narita K; Hu DL; Tsuji T; Nakane A
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):389-96. PubMed ID: 18312579
[TBL] [Abstract][Full Text] [Related]
8. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
[TBL] [Abstract][Full Text] [Related]
9. Toxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure.
Stich N; Model N; Samstag A; Gruener CS; Wolf HM; Eibl MM
Toxins (Basel); 2014 May; 6(6):1724-41. PubMed ID: 24887085
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.
Narita K; Hu DL; Asano K; Nakane A
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736
[TBL] [Abstract][Full Text] [Related]
12. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.
Chen WH; Pasetti MF; Adhikari RP; Baughman H; Douglas R; El-Khorazaty J; Greenberg N; Holtsberg FW; Liao GC; Reymann MK; Wang X; Warfield KL; Aman MJ
Clin Vaccine Immunol; 2016 Dec; 23(12):918-925. PubMed ID: 27707765
[TBL] [Abstract][Full Text] [Related]
13. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome.
Gampfer J; Thon V; Gulle H; Wolf HM; Eibl MM
Vaccine; 2002 Jan; 20(9-10):1354-64. PubMed ID: 11818153
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB
J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118
[TBL] [Abstract][Full Text] [Related]
15. Epitope mapping of neutralizing TSST-1 specific antibodies induced by immunization with toxin or toxoids.
Gampfer JM; Samstag A; Waclavicek M; Wolf HM; Eibl MM; Gulle H
Vaccine; 2002 Nov; 20(31-32):3675-84. PubMed ID: 12399195
[TBL] [Abstract][Full Text] [Related]
16. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
Bonventre PF; Heeg H; Edwards CK; Cullen CM
Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults.
Landrum ML; Lalani T; Niknian M; Maguire JD; Hospenthal DR; Fattom A; Taylor K; Fraser J; Wilkins K; Ellis MW; Kessler PD; Fahim RE; Tribble DR
Hum Vaccin Immunother; 2017 Apr; 13(4):791-801. PubMed ID: 28010246
[TBL] [Abstract][Full Text] [Related]
18. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.
Cui JC; Hu DL; Lin YC; Qian AD; Nakane A
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222
[TBL] [Abstract][Full Text] [Related]
19. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in Japanese children.
Quan L; Morita R; Kawakami S
Burns; 2010 Aug; 36(5):716-21. PubMed ID: 20036064
[TBL] [Abstract][Full Text] [Related]
20. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]